Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
1keu6gEsqUB9Xedh